IL-10 and TGF-β secreted by tumor-associated regulatory T cells restrict the function of CD8+ effector T cells and the maturation of DCs, thus further inhibiting innate immunity and adaptive immunity [45, 46]. The gene discussed is TGFB1; the disease is neoplasm.